Skip to Content
AP National Business

Sanofi drops plans for messenger RNA vaccine against virus

<i></i><br/>
KMIZ

By
Published 7:10 AM

PARIS (AP) — French drugmaker Sanofi says it is shelving plans for a COVID-19 vaccine based on messenger RNA despite positive results from early stage testing. The Paris-based company said it will continue to develop another vaccine candidate that is already undergoing late stage human trials. That vaccine, being developed with Britain’s GlaxoSmithKline, uses a different technology. Sanofi is expanding efforts to test that vaccine as a COVID-19 booster. Messenger RNA vaccines are already made by Pfizer and Moderna. Sanofi decided it wasn’t worth pursuing that technology for COVID-19 vaccines, given how widely available they are. 

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

ABC 17 News is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content